Biostax Corp. (BTAX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Oct 23, 2026
Biostax Statistics
Total Valuation
Biostax has a market cap or net worth of 21,647.
| Market Cap | 21,647 |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biostax has 108.24 million shares outstanding.
| Current Share Class | 108.24M |
| Shares Outstanding | 108.24M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 0.17 |
| P/OCF Ratio | 0.17 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.29 |
| Interest Coverage | -3.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -164.58% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 18.24% |
| Weighted Average Cost of Capital (WACC) | 19.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -467,582 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +100.00% in the last 52 weeks. The beta is 0.62, so Biostax's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +100.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.16 |
| Relative Strength Index (RSI) | 29.38 |
| Average Volume (20 Days) | 4,843 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -971,046 |
| Pretax Income | -1.87M |
| Net Income | -1.87M |
| EBITDA | -916,538 |
| EBIT | -971,046 |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 1.16M |
| Net Cash | -1.16M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -5.32M |
| Book Value Per Share | -0.06 |
| Working Capital | -5.33M |
Cash Flow
| Operating Cash Flow | 125,025 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 54,508 |
| Net Borrowing | -129,556 |
| Free Cash Flow | 125,025 |
| FCF Per Share | 0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biostax does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.93% |
| Shareholder Yield | -0.93% |
| Earnings Yield | -11,109.00% |
| FCF Yield | 577.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on May 6, 2021. It was a reverse split with a ratio of 0.001.
| Last Split Date | May 6, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.001 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |